
Open Figure 1 of a paper on retatrutide and you will see three molecular portraits side by side. Which part changes between them? Answer that and the familiar shorthand of “single”, “dual” and “triple” starts to make sense.
Where the three profiles overlap
Start with the target all three have in common. Semaglutide, tirzepatide and retatrutide can each activate the GLP-1 receptor. Now compare tirzepatide with retatrutide. Both can also activate the GIP receptor. The glucagon receptor is the distinguishing third target in retatrutide’s profile. That makes the comparison easier to remember if you start with the overlap and work outwards.
| Peptide | Receptors in its research profile |
|---|---|
| Semaglutide | GLP-1 |
| Tirzepatide | GLP-1 and GIP |
| Retatrutide | GLP-1, GIP and glucagon |
In a figure legend, those targets often appear as GLP-1R, GIPR and GCGR. The R stands for receptor. GCGR is the glucagon receptor, so a figure labelled GCGR belongs in the third row of this comparison.
One peptide, three molecular portraits
A 2024 structural study gives “triple agonist” a visual meaning. Its authors used cryo-electron microscopy to examine retatrutide bound to each of its three receptor targets. In Figure 1, look across the three reconstructions. The peptide is retatrutide in every panel. What changes from left to right is the receptor surrounding it.
It is easy to read three adjacent panels as a sequence of events. Here they depict three separate molecular complexes. Each gives researchers a view of how the same peptide fits into a different binding pocket. Look at the labels before the colours and the figure becomes a comparison you can follow without knowing every detail of the structure. View the structural study and Figure 1 on PubMed.
What a receptor count leaves out
Imagine reading the comparison table with the molecule names covered. You could still identify the triple agonist from the list of targets. Could you also draw its response curve at each receptor? The table gives you no way to do that. A target name tells you where researchers observed activity. A response curve records how a particular measured signal changed across the conditions of an experiment.
This distinction matters when two figures look similar. Read the vertical axis first. One figure might show a signal as a percentage of a reference response, while another shows the original instrument units. Even the same number means something different on those two scales. The figure legend tells you what the authors used as their reference.
Why retatrutide sometimes appears as LY3437943
Search for retatrutide by name alone and an important early paper is easy to overlook. Its title starts with LY3437943, the development code for the molecule. The later structural paper uses the name retatrutide. Knowing both terms lets you trace the same molecule across two different research questions.
Read the discovery paper to see how the authors characterised activity at the three targets. Then open the structural paper to see how they visualised the resulting complexes. Together the papers give you two kinds of evidence about the same peptide. Read the original LY3437943 discovery paper.
Matching a claim to its source
Suppose a caption says “retatrutide was identified in this sample.” The words this sample matter. A structural paper can explain the molecule’s receptor profile, while the identity of a particular sample depends on a report tied to that sample and the method used to examine it. Following the sample identifier back to the report is a different task from following a receptor label back to a research figure. How to read an independent laboratory test report.
Frequently asked questions
What do tirzepatide and retatrutide have in common?
Both have activity at the GLP-1 and GIP receptors. Retatrutide’s research profile also includes the glucagon receptor.
Does triple agonist mean a mixture of three peptides?
Here the term describes one peptide, retatrutide, with activity at three receptor targets.
Why search for LY3437943 as well as retatrutide?
LY3437943 is the development code used in the original discovery paper. Searching both terms helps connect earlier and later publications.